You are here: Industry Insights > Diabetes

News List

Xeris Pharmaceuticals and OHSU Conducting Artificial Pancreas Clinical Trial Using Xeris’ Novel Ready-to-Use Liquid Glucagon pharmafocusasia
November 27, 2018
Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize...
Big Data and AI provide better diagnosis and treatment europeanpharmaceuticalreview
November 27, 2018
MedUni Vienna researchers have developed a way to use retinal imaging to diagnose diabetes, explaining how the technique could be used for other conditions…
NHS to fund continuous blood glucose monitoring system pharmatimes
November 19, 2018
Tens of thousands of people with type I diabetes across the country are to benefit from “life-changing” glucose monitors on the NHS, NHS England has announced on World Diabetes Day.
Diabetes claims have gone up over last two years biospectrum
November 16, 2018
SBI General Insurance’s Claims Analysis reveals Indians among the age group of 18 – 35 years old are most vulnerable to diabetes
Lilly says diabetes drug Trulicity reduces heart risks in trial expressbpd
November 08, 2018
The company did not provide any details on the magnitude of risk reduction seen in the so-called outcomes trial
Some factors have a greater impact on heart attack risk in women than they do in men: The BMJ expressbpd
November 08, 2018
High blood pressure, smoking and diabetes increase the risk of heart attack in both sexes but they have more impact in women than they do in men, shows a study published by The BMJ.
Diabetes causing 500 premature deaths a week pharmatimes
November 01, 2018
A new analysis by Diabetes UK has calculated that 500 people with diabetes die prematurely every week in England and Wales, with a significant number of these deaths down to avoidable complications.
J&J's Invokana becomes first FDA-approved oral diabetes drug to reduce cardiovascular event risk pharmafile
November 01, 2018
The FDA has given the go-ahead for Johnson & Johnson’s drug Invokana (canagliflozin) for use in the risk reduction of major adverse cardiovascular (CV) events, making it the “first and only oral diabetes treatment.....
Effective preventative therapies for type 2 diabetes are underused, new research argues pharmafile
October 31, 2018
New research has warned that interventions which can effectively delay or prevent the development of type 2 diabetes are not being used to their full potential, with many being expensive or not readily accessible....
Dermira Completes Patient Enrollment in Phase 2b Dose-Ranging Study Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis biospectrumasia
October 24, 2018
Dermira Completes Patient Enrollment in Phase 2b Dose-Ranging Study Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis

Previous page 1 2 3 4 5 6 7 8 9 10 ... 37 38 Next page